An ongoing phase 3 study of the efficacy, safety, and immunogenicity of candidate malaria vaccine RTS,S/AS01 is being conducted in seven African countries.
Links:
[1] http://admin.indiaenvironmentportal.org.in/feature-article/first-results-phase-3-trial-rtssas01-malaria-vaccine-african-children
[2] http://admin.indiaenvironmentportal.org.in/category/journal/new-england-journal-medicine
[3] http://admin.indiaenvironmentportal.org.in/category/thesaurus/malaria
[4] http://admin.indiaenvironmentportal.org.in/category/thesaurus/drugs
[5] http://admin.indiaenvironmentportal.org.in/category/thesaurus/medical-research
[6] http://admin.indiaenvironmentportal.org.in/category/thesaurus/africa
[7] http://admin.indiaenvironmentportal.org.in/category/thesaurus/child-health